Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Pharma Talk Radio



Follow This Show

Stay in the know about new episodes and updates.
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

On-Demand Episodes

Learn more about the IO360° Summit at www.io360summit.com

Evaluating single cell omics to understand the heterogeneity in immune and tumor cells Multi-omic biomarkers for patient selection in solid tumor IO: is there a path to more personalized therapy? In an era of ‘targeted'... more

In this podcast, you will hear a presentation from Dr Barbara Lueckel, Roche Pharma Partnering, from the 2021 PODD Conference summarizing trends, approvals and pipelines within the drug delivery space. To learn more about the... more

Dan Chen, MD, PhD, Founder, Engenuity Life Sciences Learn more about the IO360° Summit at www.io360summit.com

This panel, first recorded at the 2022 IO360° Summit, reported on advances in achieving more diversity and inclusion in oncology clinical trials. Moderated by: Adrelia Allen, PharmD, Director, Clinical Trial Patient Diversity, Global Clinical... more

About The Episode With pharma's focus on the extension of drug release windows, new technologies are needed that can lengthen that duration. Today, Zach Fletcher of Trelleborg Healthcare & Medical provides an insight into... more

CAR T cells for solid tumors: Lessons learned from on-going clinical trials in glioblastoma. Interplay between CAR T cells and the endogenous immune system Next-generation CAR designs to overcome barriers for solid tumor CAR therapy... more

When Claas Röhl's 12-year old daughter was an infant, she was diagnosed with Neurofibromatosis Type 1 (NF), a rare genetic disorder that causes tumors to form along nerves. With no prior background in research, Claas founded NF... more

Where have we come over the past 5 years What are the approvals and approval activity over the past year? What are the challenges and issues? What have we learned? What are the real important technologies that are being developed... more

Kate Woda, IO360° Conference Director, gives a 6 minute overview on what you can expect at the 9th annual IO360° Summit taking place February 7-10 in Brooklyn, NY. Keynotes Include: Dr Carolyn Bertozzi, Stanford University... more

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled